NEW YORK – In an earlier editorial (HME Innovation: A Caregiver’s Perspective), I made an impassioned plea for HME manufacturers and suppliers to “get onboard the ‘evidence-based’ healthcare delivery train.” I also urged HME compa

WASHINGTON, DC – The newest version of the 21st Century Cures bill now includes language to extend the CMS power wheelchair prior authorization demonstration. With the current demonstration ending this August, the new provisions would extend th

WASHINGTON, DC – On August 3, Congress will start its month-long summer recess. During the recess, legislators will travel back to their districts. This is a perfect opportunity for HME providers to explain the devastating impact of using bid d

FORT COLLINS, CO – One of the benefits of writing/editing Medtrade Monday is chatting with the many I Am the HME Industry providers. Many of these providers are truly “independents,” some in the most extreme. Two weeks ago, for example, I c

WASHINGTON, DC – This time last year, CMS used their annual proposed rule on end stage renal disease payments to also announce their intent to adjust Medicare payment rates in areas outside the competitive bidding areas. Commonly referred to as

WASHINGTON, DC – Addressing CMS’ plan to apply competitive bidding-derived rates to non-competitive bidding areas, due to take effect in January of 2016, remains a top priority for the Association. 

Expanding the reach of Medicare b